准心脏:阿尔茨海默病预防的新轴心
Lawrence I Heller1, Allison S Lowe1, Thaís Del Rosario Hernández1
1Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.
Journal of dementia and alzheimer's disease
|September 10, 2025
概括
某些心脏药物可以通过模仿环素A的作用来帮助预防阿尔茨海默病. 将低剂量环素A与这些心脏药物结合起来,为大脑和心脏疾病提供了潜在的双重治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
背景情况:
- 环素A和氨酸抑制剂在预防阿尔茨海默病方面表现有前途.
- 氨酸抑制剂在斑马鱼幼虫中诱导明显的行为变化,包括过度活跃和改变的感官反应.
研究的目的:
- 为了识别与阿尔茨海默病相关的氨酸抑制剂类效应的FDA批准的药物.
- 探索阿尔茨海默病和心血管疾病的潜在协同治疗策略.
主要方法:
- 利用Z-LaP追踪器,一个神经网络模型,来选FDA批准的化合物的大型库.
- 在斑马鱼幼虫中评估药物诱导的行为特征,将其与环素A进行比较.
- 研究了心脏药物和环素A的双重使用的协同效应.
主要成果:
- 一组65种药物,包括14种心脏药物,表现出类似于环素A的行为特征.
- 心脏药物和环素A的双重使用显示出协同效应,允许更低的有效剂量.
- 发现许多已确定的心脏药物可以抑制氨酸-NFAT通路.
结论:
- 低剂量环素A与特定的心脏药物的同时使用,为阿尔茨海默病的预防和心血管治疗提供了一个可行的策略.
- 这种综合方法可以减轻与更高的环素A剂量相关的副作用.
- 与simvastatin,irbesartan,cilostazol,doxazosin或nebivolol的组合对未来的研究来说是有希望的.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.环素A 是一种环素.衰老的衰老 衰老的衰老心血管疾病心血管疾病基洛斯塔佐尔 (cilostazol) 是一种可靠的药物.痴呆症 痴呆症是一种痴呆症.多克萨佐辛 (doxazosin) 是一种多克萨佐辛药.伊尔贝萨坦是一种没有进化,没有进化.西姆瓦斯塔丁是什么意思更多相关视频
相关概念视频
01:22Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
01:26Coronary Artery Disease IV: Preventive Measures
591
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
591
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:26Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
01:17Ischemic Heart Disease: Overview
3.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
01:30Coronary Artery Disease I: Introduction
893
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
893